Search Results - david stec

3 Results Sort By:
Rapid Nuclear Receptor Fluorescence-Based Competitive Binding Assay
Project ID: 2019-47Background:Peroxisome proliferator-activated receptors (PPARs) are a class of nuclear receptors that have become significant targets for addressing various metabolic disorders, including lipid dystrophies and diabetes. PPARs are nutrient receptors that have different selective and promiscuous ligands, including fatty acids and eicosanoids....
PEGylated Bilirubin for the treatment of Hyperlipidemia, Obesity, and Type II Diabetes
Project ID: D2018-40Background:Obesity, a low-grade inflammatory disease, has affected more than 150 million people in the US. Obesity and its associated risk factors are a prelude to the development of type II diabetes that accounts for a vast majority of the 25.8 million diabetes cases in the US. Bilirubin, a yellow pigment produced during red blood...
“Thin” Molecules for Treating Obesity and Type II Diabetes
Project ID: D2016-29IP Status: PCT patent application filedInvention Description and Novelty: “Thin” molecules offer stronger binding to PPAR and include greater lipid burning and glucose lowering properties. Applications: Dyslipidemia, obesity and type II diabetes Value propositions: • Bilirubin reduces body fat percentage...